A Message From Our Program Leader
My driving force for the treatment of women with cancer is to empower patients while they face their journey ahead. I value the importance of maintaining quality of life and educating patients about available resources, including clinical trials that are evaluating novel treatments.
About Our Program
The goal of these clinical trials is to try to improve cancer therapeutic opportunities. Our program specializes in Phase IB-IV clinical trials for endometrial, cervical and ovarian cancers, led by Dr. Willmott who serves as principal investigator and program director.
Dr. Willmott is a member of the Oncology National Responsibility Group, the Society of Gynecologic Oncology and the Western Association of Gynecologic Oncologists. Dr. Willmott has been involved in many publications and presentations related to the collaborative national and international clinical trials performed at HonorHealth Cancer Care-Biltmore.